Corporate Information And Statement Of Ifrs Compliance [Abstract]

BerGenBio - Filing #5877180

Concept	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2023-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	BerGenBio ASA	—
Domicile of entity	—	Norway	—
Legal form of entity	—	public limited liability	—
Country of incorporation	—	Norway	—
Address of entity's registered office	—	Nygårdsgaten 114, 5008 Bergen, Norway	—
Description of nature of entity's operations and principal activities	—	is a clinical-stage	—
Name of parent entity	—	BerGenBio ASA	—
Statement of IFRS compliance [text block]	—	Basis for preparation	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade payables	12,924,000 NOK	—	18,605,000 NOK
Disclosure of material accounting policy information [text block]	—		—
Explanation of sources of estimation uncertainty with significant risk of causing material adjustment	—		—
Disclosure of objectives, policies and processes for managing capital [text block]	—	Capital management	—